{
    "organizations": [],
    "uuid": "a72a51e8e05244a9b46a1ffcdcb9b83b5c09aad5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biocryst-receives-european-medicin/brief-biocryst-receives-european-medicines-agency-approval-for-alpivab-for-treatment-of-influenza-idUSFWN1S806B",
    "ord_in_thread": 0,
    "title": "BRIEF-BioCryst Receives European Medicines Agency Approval For Alpivab For Treatment Of Influenza",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1 (Reuters) - BioCryst Pharmaceuticals Inc:\n* BIOCRYST RECEIVES EUROPEAN MEDICINES AGENCY APPROVAL FOR ALPIVABâ„¢ FOR TREATMENT OF INFLUENZA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-01T18:11:00.000+03:00",
    "crawled": "2018-05-02T15:47:43.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "biocryst",
        "pharmaceutical",
        "inc",
        "biocryst",
        "receives",
        "european",
        "medicine",
        "agency",
        "approval",
        "treatment",
        "influenza",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}